Campbell NL, Holden R, Boustani MA. Preventing Alzheimer disease by deprescribing anticholinergic medications. JAMA Intern Med. 2019;179(8):1093–1094. doi: 10.1001/jamainternmed.2019.0676
Cohen PA, Avula B, Wang YH, Zakharevich I, Khan I. Five unapproved drugs found in cognitive enhancement supplements. Neurol Clin Pract. 2021;11(3):e303–e307. doi: 10.1212/CPJ.0000000000000960
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control For Further Reading 245 study. JAMA Intern Med. 2019;179(8):1084–1093. doi: 10.1001/jamaintern
Crowe S, Stranks E. The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Arch Clin Neuropsychol. 2018;33:901–911. doi: 10.1093/arclin/acx120
D’Amico G, deFranchis R, Dell’Era A, eds. National history and stages of cirrhosis and variceal hemorrhage. Springer Science+Business Media; 2014. doi: 10.1007/978-1-4939-0002-2_2
Esser MB, Sherk A, Liu Y, et al. Deaths and years of potential life lost from excessive alcohol use – United States, 2011–2015. Morbidity and Mortality Weekly Report. 2020;69:981–987. doi: 10.15585/mmwr.mm6930a1
Flippo TS, Holder WD. Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. Arch Surg. 1993;128(12):1391–1395. doi: 10.1001/archsurg.1993.01420240099018
Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–407. doi: 10.1001/jamainternmed.2014.7663
Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986;49:341–345.
He Q, Chen X, Wu T, Li L, Fei X. Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies. J Clin Neurol. 2019;15(1):9–19. doi: 10.3988/jcn.2019.15.1.9. Epub 2018 Oct 26.
Islam MM, Iqbal U, Walther B, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016;47:181–191. doi: 10.1159/000454881
Kim JW, Lee DY, Lee BC, et al. Alcohol and cognition in the elderly: a review. Psychiatry Investig. 2012;9:8–16. doi: 10.4306/pi.2012.9.1.8
Kivimäki M, Singh-Manoux A, Batty GD, et al. Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Netw Open. 2020;3(9):e2016084. doi: 10.1001/jamanetworkopen.2020.16084
National Institute on Alcohol Abuse and Alcoholism. Alcohol facts and statistics. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/alcohol-facts-and-statistics
Oscar-Berman M, Marinkovic K. Alcoholism and the brain: an overview. Alcohol Res Health. 2003;27(2):125–133.
Paterniti S, Dufouil C, Alpérovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol. 2002;22(3):285–293.
Raphael KC, Matuja SS, Shen NT, Liwa AC, Jaka H. Hepatic encephalopathy; prevalence, precipitating factors and challenges of management in a resource-limited setting. J Gastrointest Digest Syst. 2016;6(3):441. doi: 10.4172/2161-069X.1000441
Rösner S, Soyka M, Hajak G, Wehrle R, Englbrecht C. Eszopiclone for insomnia. Cochrane Database System Rev. 2013;8(CD010703). doi: 10.1002/14651858.CD010703
Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–513. doi: 10.1001/archinternmed.2007.106
Sabia S, Elbaz A, Britton A, Bell S, Dugravot A, Shipley M, Kivimaki M, Singh-Manoux A. Alcohol consumption and cognitive decline in early old age. Neurology. 2014;82(4):332–339. doi: 10.1212/WNL.0000000000000063. Epub 2014 Jan 15.
Sacks O, Shulman M. Steroid dementia: An overlooked diagnosis? Neurology. 2005;64:707–709.
Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J; QalyDays Study Group. Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3(3):e124–132. doi: 10.1016/S2468-2667(18)30022-7. Epub 2018 Feb 21.
Topiwala A, Allan CL, Valkanova V, et al. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ. 2017;357:j2353. doi: 10.1136/bmj.j2353
Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715–735. doi: 10.1002/hep.27210. Epub 2014 Jul 8.
Weigand AJ, Bondi MW, Thomas KR, et al. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology. 2020;95(16) e2295–e2304. doi: 10.1212/WNL.0000000000010643
Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39(3):739–745. doi: 10.1002/hep.20095
Wright JD, Cogan JC, Huang Y, et al. Association of new perioperative benzodiazepine use with persistent benzodiazepine use. JAMA Netw Open. 2021;4(6):e2112478. doi: 10.1001/jamanetworkopen.2021.12478
Wu CS, Ting TT, Wang SC, Chang IS, Lin KM. Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry. 2011;19(2):151–159. doi: 10.1097/JGP.Ob013e3181e049ca
Zhang R, Shen L, Miles T, et al. Association of low to moderate alcohol drinking with cognitive functions from middle to older age among US adults. JAMA Netw Open. 2020;3(6):e207922. doi: 10.1001/jamanetworkopen.2020.7922
Bamia C, Trichopoulou A, Trichopoulos D. Age at retirement and mortality in a general population sample: the Greek EPIC study. Am J Epidemiol. 2008;167(5):561–569. doi: 10.1093/aje/kwm337. Epub 2007 Dec 3.
Bialystok E. Bilingualism: pathway to cognitive reserve. Trends Cogn Sci. 2021;25(5):355–364. doi: 10.1016/j.tics.2021.02.003. Epub 2021 Mar 23.
Biddle KD, Jacobs HIL, d’Oleire Uquillas F, et al. Associations of widowhood and β-amyloid with cognitive decline in cognitively unimpaired older adults. JAMA Netw Open. 2020;3(2):e200121. doi: 10.1001/jamanetworkopen.2020.0121
Brenowitz WD, Besser LM, Kukull WA, Keene CD, Glymour MM, Yaffe K. Clinician-judged hearing impairment and associations with neuropathologic burden. Neurology. 2020;95(12):e1640–e1649; doi: 10.1212/WNL.0000000000010575
Bubbico G, Chiacchiaretta P, Parenti M, et al. Effects of second language learning on the plastic aging brain: functional connectivity, cognitive decline, and reorganization. Front Neurosci. 2019;13:423. doi: 10.3389/fnins.2019.00423. eCollection 2019.
Deal JA, Goman AM, Albert MS, et al. Hearing treatment for reducing cognitive decline: design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial. Alzheimer Dement. 2018;4:499–507. doi: 10.1016/j.trci.2018.08.007 248 For Further Reading
Dekhtyar S, Marseglia A, Xu W, Darin-Mattsson A, Wang HX, Fratiglioni L. Genetic risk of dementia mitigated by cognitive reserve: a cohort study. Ann of Neurol. 2019;86(1):68–78. doi: 10.1002/ana.25501. Epub 2019 May 22.
Devere R. Music and dementia: an overview. Pract Neurol. 2017. https://practical neurology.com/articles/2017-june/music-and-dementia-an-overview/pdf
Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF III. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329–335. doi: 10.1192/bjp.bp.112.118307
Ehrlich JR, Goldstein J, Swenor BK, Whitson H, Langa KM, Veliz P. Addition of vision impairment to a life-course model of potentially modifiable dementia risk factors in the US. JAMA Neurol. 2022 Jun 1;79(6):623–626. doi: 10.1001/jamaneurol.2022.0723. Erratum in: JAMA Neurol. 2022 Jun 1;79(6):634.
Fancourt D, Steptoe A. Television viewing and cognitive decline in older age: findings from the English Longitudinal Study of Ageing. Sci Rep. 2019;9(1):2851. doi: 10.1038/s41598-019-39354-4
Golub JS, Brickman AM, Ciarleglio AJ, Schupf N, Luchsinger JA. Association of subclinical hearing loss with cognitive performance. JAMA Otolaryngol Head Neck Surg. 2020 Jan 1;146(1):57–67. doi: 10.1001/jamaoto.2019.3375
Griffiths TD, Lad M, Kumar S, et al. How can hearing loss cause dementia? Neuron. 2020;108(3):401–412. doi: 10.1016/j.neuron.2020.08.003. Epub 2020 Aug 31.
Guzzo R, Nalbantian H. Is the gig economy the answer for older workers? May 9, 2019. https://www.brinknews.com/is-the-gig-economy-the-answer-for-older-workers/
Harshfield EL, Pennells L, Schwartz JE, et al. Association between depressive symptoms and incident cardiovascular diseases. J Am Med Assoc. 2020;324(23):2396–2405. doi: 10.1001/jama.2020.23068
Hwang PH, Longstreth WT Jr., Brenowitz WD, et al. Dual sensory impairment in older adults and risk of dementia from the GEM Study. Alzheimers Dement. 2020;12(1):e12054. doi: 10.1002/dad2.12054
Kable JW, Caulfield MK, Falcone M, et al. No effect of commercial cognitive training on brain activity, choice behavior, or cognitive performance. J Neurosci. 2017,37(31):7390–7402. doi: 10.1523/JNEUROSCI.2832-16.2017
Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshFor Further Reading 249 old for clinically overt dementia. Acta Neuropathologica. 2017;134(2):171–186. doi: 10.1007/s00401-017-1717-7. Epub 2017 May 9.